MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis..

After the initial vaccination (week 3), only mice vaccinated with 4pox/LT had statistically significant neutralizing responses compared to negative control animals (p = 0.0004) (

The escape mutant HAs (D43N, D45Y, G46E, G139E, and K140E) were overexpressed in 293T cells and analyzed by flow cytometry (Figure 3C and 3D) to determine whether conforma-

To test whether altered receptor-binding properties of the viral HA glycoprotein of highly pathogenic A/Vietnam/1203/04 (H5N1) influenza virus can reduce susceptibility to NA

Results showed that mice vaccinated intranasally with live Bac-HA showed 100% protection against lethal H7N7 influenza virus, whereas no protection was observed in mice vaccinated

According to expression patterns of FGFR family members in A549 cells, we investigated the effect of FGFR1 and FGFR4 on influenza A/PR8 and H5N1 virus infection.. A549 cells

Here we established primary culture of undifferentiated and well differentiated normal human bronchial epithelial (NHBE) cells and infected with highly pathogenic influenza H5N1

Ferrets that received 2 doses of VN04 ca virus or the H5 HA DNA prime-VN04 ca virus boost regimen had serum Nt and HAI Ab responses against antigenically distinct H5N1 viruses